Literature DB >> 18757388

Hyperhomocysteinemia and lower extremity wounds.

Elissa M Schwartzfarb1, Paolo Romanelli.   

Abstract

Chronic lower extremity wounds include ulceration of the leg and foot. The underlying pathology that causes these conditions includes venous insufficiency, arterial disease, diabetes, and other less common disorders. Since the introduction of the homocysteine theory more than 30 years ago, considerable evidence has demonstrated hyperhomocysteinemia to be an independent risk factor for venous and arterial thrombosis, atherosclerosis and cardiovascular disease. Although any cause-effect relationship remains to be determined, hyperhomocysteinemia as a risk factor for these events suggests that elevated levels of homocysteine may also be a marker of chronic lower limb ulceration. This review addresses the metabolism of homocysteine, mechanisms of vascular injury, a role for hyperhomocysteinemia in lower extremity wounds and possible means of treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18757388     DOI: 10.1177/1534734608322490

Source DB:  PubMed          Journal:  Int J Low Extrem Wounds        ISSN: 1534-7346            Impact factor:   2.057


  4 in total

1.  Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus.

Authors:  Carmine Gazzaruso; Adriana Coppola; Tiziana Montalcini; Elisabetta Baffero; Adriana Garzaniti; Gabriele Pelissero; Silvia Collaviti; Annalisa Grugnetti; Pietro Gallotti; Arturo Pujia; Sebastiano B Solerte; Andrea Giustina
Journal:  Endocrine       Date:  2011-10-11       Impact factor: 3.633

2.  Hyperhomocysteinaemia and chronic venous ulcers.

Authors:  Stefano de Franciscis; Giovambattista De Sarro; Paola Longo; Gianluca Buffone; Vincenzo Molinari; Domenico M Stillitano; Luca Gallelli; Raffaele Serra
Journal:  Int Wound J       Date:  2013-02-19       Impact factor: 3.315

Review 3.  Wound Healing: A Comprehensive Review.

Authors:  Yasser H Almadani; Joshua Vorstenbosch; Peter G Davison; Amanda M Murphy
Journal:  Semin Plast Surg       Date:  2021-07-15       Impact factor: 2.195

4.  Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis.

Authors:  Andrew T Jacovina; Arunkumar B Deora; Qi Ling; M Johan Broekman; Dena Almeida; Caroline B Greenberg; Aaron J Marcus; Jonathan D Smith; Katherine A Hajjar
Journal:  J Clin Invest       Date:  2009-10-19       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.